medigraphic.com
Academia Mexicana de Neurología, A.C.

2012, Number 5

<< Back Next >>

Rev Mex Neuroci 2012; 13 (5)

Acute cerebrovascular disease discharges from public institutions of the Mexican Ministry of Health: An analysis on 5.3 millions of hospitalizations in 2010

Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Villarreal-Careaga J, León-Jiménez C, Barinagarrementería F, Cantú-Brito C

Language: Spanish
References: 33
Page: 252-258
PDF size: 202.36 Kb.


ABSTRACT

Introduction: Cerebrovascular disease (CVD) mortality in Mexico has shown a growing pattern in recent years. It is not known whether data obtained in the important multicenter CVD Mexican registries adequately represent all the hospital units of the health system. Objective: To describe the frequency of acute CVD subtypes and shortterm outcome in discharge registries from public institutions of the Mexican health system, during the year 2010. Methods: We consulted the Mexican public health system database of hospital discharges corresponding to the year 2010 (Secretaría de Salud, IMSS, IMSS Oportunidades, ISSSTE, PEMEX, SEMAR y SEDENA). CVD registries were identified with the International Classification of Diseases 10th revision codes (ICD-10). Specified CVD was defined as the existence of ICD-10 codes describing precise CVD subtypes. Results: In 2010, a total of 5,314,132 hospital discharges were registered in the Mexican public health system. Of them, 46,247 (0.9%) were acute CVD including: acute ischemic stroke (AIS) 20,298 (43.9%), intracerebral hemorrhage (ICH) 6,005 (13.0%), subarachnoid hemorrhage 2,655 (5.7%), cerebral venous thrombosis (CVT) 194 (0.4%) and non-specified CVD 17,095 (37.0%). Among specified CVD discharges (n=29,152), 69.6% corresponded to AIS, 20.6% to ICH, 9.1% to SAH and 0.7% to CVT. The global 30-day case fatality rate was 17.1% (18.8% among specified subtypes); higher for ICH (33.6%), followed by SAH (29.3%) and AIS (13.9%) (p ‹ 0.001). Conclusions: The relative frequency of acute CVD subtypes by the year 2010 was similar to that of the previous Mexican multicenter registries. Short-term mortality is higher in hemorrhagic forms of CVD, as compared with ischemic stroke.


REFERENCES

  1. Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Villarreal- Careaga J, Barinagarrementería F, Cantú-Brito C, para los miembros de AMEVASC. Mortalidad por enfermedad vascular cerebral en México, 2000-2008: Una exhortación a la acción. Rev Mex Neuroci 2011; 12: 235-41.

  2. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009; 8: 345-54.

  3. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. Lancet Neurol 2009; 8: 355-69.

  4. Grau AJ, Weimar Ch, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke. The German Stroke Data Bank. Stroke 2001; 32: 2559-66.

  5. Barquera S, Campos-Nonato I, Hernández-Barrera L, Villalpando S, Rodríguez- Gilabert C, Durazo-Arvizú R, Aguilar-Salinas CA. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52: S63-71.

  6. Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Avila MA, Gaona B, Rebollar R, Hernández L. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Publica Mex 2010; 52: S19-26.

  7. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, Rivera JA. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2009; 51: S595-603.

  8. Aguilar-Salinas CA, Gómez-Pérez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52: S44-53.

  9. Villalpando S, Rodrigo JR. The status of non-transmissible chronic disease in Mexico based on the National Health and Nutrition Survey 2006. Introduction. Salud Publica Mex 2010; 52(Suppl. 1): S2-3.

  10. Villalpando S, Shamah-Levy T, Rojas R, Aguilar-Salinas CA. Trends for type 2 diabetes and other cardiovascular risk factors in Mexico from 1993-2006. Salud Publica Mex 2010; 52: S72-9.

  11. Cantú-Brito C, Ruiz-Sandoval JL, Chiquete E, Arauz A, León-Jiménez C, Murillo- Bonilla LM, Villarreal-Careaga J, et al. Factores de riesgo y pronóstico de los tipos de enfermedad vascular cerebral en México. Rev Mex Neuroci 2011; 12: 224-34.

  12. Cantú-Brito C, Ruiz-Sandoval JL, Arauz-Góngora A, Villarreal-Careaga J, Barinagarrementería F, Murillo-Bonilla LM, Chiquete E, et al. Prevalencia de estenosis carotídea en pacientes con isquemia cerebral transitoria en México. Rev Mex Neuroci 2010; 11: 343-8.

  13. Murillo-Bonilla LM, Lizola-Hernández J, Lepe-Cameros L, Ruiz-Sandoval JL, Chiquete E, León-jiménez C, Arauz A, et al. Factores predictivos de discapacidad funcional y muerte a 30 días en sujetos con infarto cerebral agudo: Resultados del Registro Nacional Mexicano de Enfermedad Vascular Cerebral (estudio RENAMEVASC). Rev Mex Neuroci 2011; 12: 68-75.

  14. Arauz A, Cantú C, Ruiz-Sandoval JL, Villarreal-Careaga J, Barinagarrementeria F, Murillo-Bonilla L, Fernández JA, et al. Pronóstico a corto plazo de la isquemia cerebral transitoria. Registro multicéntrico de enfermedad vascular cerebral en México. Rev Inv Clin 2006; 58: 530-9.

  15. Ruiz-Sandoval JL, Cantú C, Chiquete E, León-Jiménez C, Arauz A, Murillo- Bonilla LM, et al. Aneurysmal subarachnoid hemorrhage in a Mexican multicenter registry of cerebrovascular disease: the RENAMEVASC registry. J Stroke Cerebrovasc Dis 2009; 18: 48-55.

  16. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jiménez C, Arauz A, Villarreal-Careaga J, et al. The first Mexican multicenter register on ischaemic stroke (the PREMIER study): demograpHICs, risk factors and outcome. Int J Stroke 2011; 6: 93-4.

  17. Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jiménez C, Arauz A, Villarreal-Careaga J, et al. Acute care and one-year outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol 2010; 51: 641-9.

  18. Cantu-Brito C, Majersik JJ, Sánchez BN, Ruano A, Becerra-Mendoza D, Wing JJ, Morgenstern LB. Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the Brain Attack Surveillance in Durango Study. Stroke 2011; 42: 601-6.

  19. Cantu-Brito C, Majersik JJ, Sánchez BN, Ruano A, Quiñones G, Arzola J, Morgenstern LB. Hospitalized stroke surveillance in the community of Durango, Mexico: the brain attack surveillance in Durango study. Stroke 2010; 41: 878-84.

  20. Chiquete E, Guareña-Serrano C, Bañuelos-Becerra LJ, Leal-Mora D, Flores-Castro M, Ochoa-Guzmán A, Ruiz-Sandoval JL. Infarto cerebral agudo en octogenarios: Factores de riesgo y mortalidad intrahospitalaria en un hospital de referencia de México. Rev Mex Neuroci 2012; 13: 139-45.

  21. Chiquete E, Valle-Rojas D, Rodríguez-Saldaña J, Rodríguez-Flores M, Aguirre- García J, Flores-Silva F, Reyes-Melo I, et al. Aterosclerosis carotídea e intracraneal en una población pediátrica: un estudio de autopsia. Rev Mex Neuroci 2012; 13: 93-7.

  22. [Statistics of hospital discharges of the National Health System public sector, 2002]. Salud Publica Mex 2003; 45: 512-33.

  23. [Statistics of National Health System public sector hospital discharges, 2001]. Salud Publica Mex 2003; 45: 310-27.

  24. [Statistics of hospital discharges in the public sector of the National Health System, 2000]. Salud Publica Mex 2002; 44: 158-87.

  25. Egresos hospitalarios SINAIS, México. Consultado en junio 01, 2012. (http:/ /www.sinais.salud.gob.mx/)

  26. Lavados PM, Hennis AJM, Fernandes JG, Medina MT, Legetic B, Hoppe A, et al. Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol 2007; 6: 362-72.

  27. Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol 2004; 3: 391-3.

  28. Lavados PM, Hennis AJ, Fernandes JG, Medina MT, Legetic B, Hoppe A, Sacks C, Jadue L, Salinas R. Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol 2007; 6: 362-72.

  29. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355-69.

  30. Mirzaei M, Truswell AS, Arnett K, Page A, Taylor R, Leeder SR. Cerebrovascular disease in 48 countries: secular trends in mortality 1950-2005. J Neurol Neurosurg Psychiatry 2012; 83: 138-45.

  31. Link J, Glazer C, Torres F, Chin K. International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies. Chest 2011; 139: 497-504.

  32. Cheng TJ, Chang CY, Lin CY, Ke DS, Lu TH, Kawachi I. State Differences in the Reporting of Unspecified Stroke on Death Certificates: Implications for Improvement. Stroke 2012 Oct 2. [Epub ahead of print]

  33. Díaz A, Gerschcovich ER, Díaz AA, Antía F, Gonorazky S. Seasonal Variation and Trends in Stroke Hospitalizations and Mortality in a South American Community Hospital. J Stroke Cerebrovasc Dis 2012 May 19. [Epub ahead of print]




2020     |     www.medigraphic.com